Literature DB >> 15971316

Treatment planning for scanned ion beams.

M Krämer1, O Jäkel, T Haberer, E Rietzel, D Schardt, M Scholz, J F Wang, U Weber, W Weyrather.   

Abstract

Since 1997 a radiotherapy unit using fast carbon ions is operational at GSI. An intensity-controlled magnetic raster scanner together with a synchrotron allowing fast energy variation enable a unique method of purely active dose shaping in three dimensions. This contribution describes the necessary steps to establish a treatment planning system for this novel modality. We discuss the requirements for the physical beam model and the radiobiological model. Based on these we chose to implement a home-grown pencil beam model to describe the ion-tissue interaction and the Local Effect Model to calculate the RBE voxel-by-voxel. Given the large number of degrees of freedom biological dose optimization must be achieved by means of inverse treatment planning. All ion-related aspects are collected in our TRiP98 software. Biological dosimetry measuring cell survival in two dimensions turns out to be a good way to verify the model predictions as well as the actual irradiation procedure. We show a patient example and outline the future steps towards a dedicated clinic facility for all light ions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15971316     DOI: 10.1016/s0167-8140(04)80021-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Respiratory motion management using audio-visual biofeedback for respiratory-gated radiotherapy of synchrotron-based pulsed heavy-ion beam delivery.

Authors:  Pengbo He; Qiang Li; Xinguo Liu; Zhongying Dai; Ting Zhao; Tingyan Fu; Guosheng Shen; Yuanyuan Ma; Qiyan Huang; Yuanlin Yan
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

2.  Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.

Authors:  Laila König; Peter Haering; Clemens Lang; Mona Splinter; Bastian von Nettelbladt; Fabian Weykamp; Philipp Hoegen; Jonathan W Lischalk; Klaus Herfarth; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.